T-Lymphokine-Activated Killer Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Glioma

Oncotarget - United States
doi 10.18632/oncotarget.23674
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

T‐lymphokine‐activated Killer Cell‐originated Protein Kinase (TOPK)‐positive Colorectal Tumor Growth Is Suppressed by Acetylshikonin

British Journal of Pharmacology
Pharmacology
2020English

Cloning and Expression of a Novel MAPKK-like Protein Kinase, Lymphokine-Activated Killer T-Cell-Originated Protein Kinase, Specifically Expressed in the Testis and Activated Lymphoid Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Mitotic Kinase PBK/TOPK as a Therapeutic Target for Adult T‑cell Leukemia/Lymphoma

International Journal of Oncology
Cancer ResearchOncology
2018English

Phosphorylation of IκBα at Serine 32 by T-Lymphokine-Activated Killer Cell-Originated Protein Kinase Is Essential for Chemoresistance Against Doxorubicin in Cervical Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Smaller Protein, Larger Therapeutic Potential: PPM1D as a New Therapeutic Target in Brainstem Glioma

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2014English

Protein Kinase C as a Therapeutic Target

Clinical Cancer Research
Cancer ResearchOncology
2006English

peIF4E as an Independent Prognostic Factor and a Potential Therapeutic Target in Diffuse Infiltrating Astrocytomas

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2016English

The Roles of Protein Kinase R in Cancer: Potential as a Therapeutic Target

Cancer Science
Cancer ResearchMedicineOncology
2018English

COL12A1, a Novel Potential Prognostic Factor and Therapeutic Target in Gastric Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy